Advertisement

Topics

Merck Merck Company Profile

14:49 EST 18th November 2017 | BioPortfolio

For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.


News Articles [1586 Associated News Articles listed on BioPortfolio]

Pharma Q3 Results Preview: Merck & Co., Merck KGaA

Investors will be eager to hear updates on Merck & Co.'s Keytruda market share versus other PD-1/L1 competitors in lung...   

Merck Ventures: Success in funding early innovation

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core busi...

Merck Foundation established

Merck, a leading science and technology company, today announced the establishment of the Merck Foundation. Through this foundation Merck combines many of its corporate responsibility activities under...

Executive Board Changes at Merck

The Personnel Committee of E. Merck KG has decided on changes in the responsibilities of the Executive Board of Merck KGaA, Darmstadt, effective September 1, 2017. Walter Galinat (61) will hand over...

Merck erzielt Pharma-Erfolg mit neuer Tablette: Die EU hat das Medikament Cladribin von Merck zugelassen. ...

Die EU hat das Medikament Cladribin von Merck zugelassen. Es soll das erste Mittel gegen Multiple Sklerose sein, das oral verabreicht wird. Für die schwächelnde Merck-Sparte ist die Zulassung ein g....

STAT Plus: Merck lays off 1,800 U.S. sales rep to overhaul its primary care marketing

A Merck spokeswoman confirmed the move, which was disclosed to Merck employees on Thursday and is expected to be completed by early January.

STAT Plus: Merck lays off 1,800 U.S. sales reps to overhaul its primary care marketing

A Merck spokeswoman confirmed the move, which was disclosed to Merck employees on Thursday and is expected to be completed by early January.

Merck Moves Lower After Stopping Development Of Hepatitis C Treatments

KENILWORTH (NJ) (dpa-AFX) - Shares of Merck (MRK) are seeing notable weakness in afternoon trading on Friday, sliding by 1.1 percent. Merck is on pace to end the session at its lowest closing leve...

PubMed Articles [9 Associated PubMed Articles listed on BioPortfolio]

Merck KGaA lands four Vertex cancer programs.

Merck KGaA, F-Star shake on immune-oncology bispecifics.

Reactivation of Herpes Zoster Keratitis With Corneal Perforation After Zoster Vaccination.

We present a case of reactivated herpes zoster keratouveitis of 6 years duration with corneal perforation requiring penetrating keratoplasty shortly after inoculation with herpes zoster vaccine (Zosta...

Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling.

Merck & Co., Inc. (Kenilworth, New Jersey) has recently published an integrated strategy for implementation of dried blood spots (DBS) in late-stage trials for population pharmacokinetic (PK) modeling...

CHEMGENIE: integration of chemogenomics data for applications in chemical biology.

Increasing amounts of biological data are accumulating in the pharmaceutical industry and academic institutions. However, data do not equal actionable information, and guidelines for appropriate data ...

Clinical Trials [77 Associated Clinical Trials listed on BioPortfolio]

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' trivalent MMR (Priorix®), comparing it to Merck's MMR vaccine (M-M-R®II), which is approved for...

Study of EMD531444 in Subjects With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome ...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

The purpose of this study is to support licensure of GSK Biologicals' MMR vaccine (Priorix®) in the US by generating immunogenicity and safety data in contrast to the US standard of care,...

Immunogenicity of GSK Bio's HPV Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

HPV infection has been established as a necessary cause of cervical cancer. GSK Biologicals has developed an HPV-16/18 L1 VLP AS04 vaccine which targets the 2 most common oncogenic HPV typ...

Companies [137 Associated Companies listed on BioPortfolio]

Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

The Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

Merck & Co

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. ...

Merck Animal Health

Today's Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global ...

Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono ...

More Information about "Merck Merck" on BioPortfolio

We have published hundreds of Merck Merck news stories on BioPortfolio along with dozens of Merck Merck Clinical Trials and PubMed Articles about Merck Merck for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merck Merck Companies in our database. You can also find out about relevant Merck Merck Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record